- IP hearings this week
- IP trials
- IP Judicial review hearings
- IP appeals at the Federal Court of Appeal
(As published on the Federal Court and Federal Court of Appeal websites on Mar 5, 2021 at 00:00:00)
This week in IP
| Date | File No. | Type | Name | Location | Length |
| Mar 5, 2021 | T-952-20 | CMC | Google Llc V. Sonos, Inc. (Patent) | Toronto | 30 m |
| Mar 8, 2021 | T-396-13 | T | Hospira Healthcare Corp. Et Al. V. Kennedy Institute Of Rheumatology Et Al. (Patent - Infliximab*) | Toronto | 10 d |
| Mar 8, 2021 | T-671-20 | CMC | Sunovion Pharmaceuticals Canada Inc. Et Al V. Taro Pharmaceuticals Inc. (Patent - Lurasidone*) | Toronto | 30 m |
| Mar 8, 2021 | T-1182-19 | CMC | Chocoladefabriken Lindt & Sprungli Ag V. 4542410 Canada Inc. (Trade Mark) | Toronto | 30 m |
| Mar 8, 2021 | T-1050-20 | M | Surewerx Usa Inc. Et Al. V. Dentec Safety Specialists, Inc. (unknown) | Ottawa | 3 h |
| Mar 9, 2021 | T-1488-20 | M | Steelhead Lng (aslng) Ltd Et Al. V. Seven Gens Energy Ltd, Rockies Lng Et Al (Patent) | Ottawa | 2 h |
| Mar 9, 2021 | T-759-16 | SENT | Bell Canada Et Al V. Watchnsavenow Inc. Et Al (Copyright) | Toronto | 2 d |
| Mar 9, 2021 | A-91-20 | APP | Spectrum Brands Inc. V. Schneider Electric Industries Sas (Trade-mark) | Ottawa | 3 h |
| Mar 10, 2021 | T-2072-19 | M | Boehringer Ingelheim (canada) Ltd. Et Al V. Teva Canada Limited (Patent - Aftinib*) | Toronto | 1 d |
| Mar 10, 2021 | T-1861-17 | M | Denis Cimaf Inc. C. Fecon Inc. (Trade Mark) | Montréal | 5 h |
| Mar 10, 2021 | T-451-20 | MCF | Kobold Corporation Et Al. V. Ncs Multistage Inc. (Patent) | Calgary | 4 h |
| Mar 10, 2021 | T-1420-18 | CMC | Ncs Multistage Inc. V. Kobold Corporation, Et Al (Patent) | Calgary | 1 h |
| Mar 11, 2021 | T-270-20 | M | Bayer Inc. Et Al V. Pharmascience Inc. (Patent) | Ottawa | 3 h |
| Mar 11, 2021 | T-142-21 | CMC | The Canadian Corps Of Commissionaires V. Gotocanada Immigration Service Ltd. (Trade Mark) | Ottawa | 1 h |
| Mar 11, 2021 | T-900-20 | MSC | The Toronto Regional Real Estate Board V. Ims Incorporated C.o.b. As Restats (Copyright) | Toronto | 3 h |
| Mar 11, 2021 | T-1662-17 | PTC | Crocs Canada, Inc. And Crocs Inc. V. Double Diamond Distribution Ltd. (Trade Mark) | Ottawa | 2 h |
Return to top.
Scheduled IP Trials
| Date | File No. | Name | Location | Length |
| Mar 8, 2021 | T-396-13 | Hospira Healthcare Corp. Et Al. V. Kennedy Institute Of Rheumatology Et Al. (Patent - Infliximab*) | Toronto | 10 d |
| Mar 22, 2021 | T-899-19 | Hoffman-la Roche Limited Et Al. V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 7.5 h |
| Mar 22, 2021 | T-1187-19 | Bayer Inc. And Other V. Dr. Reddy's Laboratories Ltd And Others (Patent - Rivaroxaban*) | Ottawa | 9 d |
| Mar 22, 2021 | T-898-19 | Hoffman-la Roche Limited Et Al. V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 7.5 h |
| Mar 22, 2021 | T-896-19 | Hoffmann-la Roche Limited Et Al. V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 7.5 h |
| Mar 22, 2021 | T-897-19 | Hoffmann-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 7.5 h |
| Mar 29, 2021 | T-396-13 | Hospira Healthcare Corp. Et Al. V. Kennedy Institute Of Rheumatology Et Al. (Patent - Infliximab*) | Toronto | 2 d |
| Mar 29, 2021 | T-151-16 | Angelcare Development Inc. Et Al. V. Munchkin, Inc Et Al. (Patent) | Ottawa | 12 d |
| Apr 12, 2021 | T-1434-14 | Pharmascience Inc. V. Pfizer Canada Ulc (PMNOC - Section 8 - Pregabalin*) | Toronto | 20 d |
| Apr 19, 2021 | T-449-17 | Farmobile, Llc. V. Farmers Edge Inc. (Patent) | Vancouver | 15 d |
| Apr 27, 2021 | T-151-16 | Angelcare Development Inc. Et Al. V. Munchkin, Inc Et Al. (Patent) | Ottawa | 3 d |
| May 14, 2021 | T-1434-14 | Pharmascience Inc. V. Pfizer Canada Ulc (PMNOC - Section 8 - Pregabalin*) | Toronto | 1 d |
| May 17, 2021 | T-123-15 | Bauer Hockey Corp. V. Sport Maska Inc. D.b.a. Ccm Hockey (Patent) | Ottawa | 25 d |
| Jun 14, 2021 | T-40-18 | Paid Search Engine Tools, Llc V. Google Canada Corporation Et Al (Patent) | Ottawa | 13 d |
| Jun 14, 2021 | T-1749-19 | Searchlight Pharma Inc. C. Jamp Pharma Corporation (Patent - Darifenacin*) | Montréal | 8 d |
| Jun 28, 2021 | T-1749-19 | Searchlight Pharma Inc. C. Jamp Pharma Corporation (Patent - Darifenacin*) | Montréal | 2 d |
| Jul 5, 2021 | T-40-18 | Paid Search Engine Tools, Llc V. Google Canada Corporation Et Al (Patent) | Ottawa | 2 d |
| Jul 19, 2021 | T-1642-16 | Fluid Energy Group Ltd. V. Mud Master Drilling Fluid Services Ltd. (Patent) | Calgary | 10 d |
| Aug 30, 2021 | T-913-17 | Canadian National Railway Company V. Bnsf Railway Company Et Al. (Patent) | Toronto | 15 d |
| Sep 1, 2021 | T-2072-19 | Boehringer Ingelheim (canada) Ltd. Et Al V. Teva Canada Limited (Patent - Aftinib*) | Toronto | 11 d |
| Oct 12, 2021 | T-28-20 | Astrazeneca Canada Inc. Et Al V. Sandoz Canada Inc. (Patent - Saxagliptin*) | Toronto | 9 d |
| Oct 18, 2021 | T-34-20 | Amgen Inc. Et Al V. Purdue Pharma (Patent - Pegfilgrastim*) | Toronto | 10 d |
| Oct 25, 2021 | T-1606-18 | Richards Packaging Inc. V. Distrimedic Inc (Patent) | Montréal | 15 d |
| Nov 1, 2021 | T-315-20 | Sunovion Pharmaceuticals Canada Inc. Et Al V. Pharmascience Inc. (Patent - Lurasidone*) | Toronto | 10 d |
| Nov 15, 2021 | T-815-17 | Pharmascience Inc. V. Meda Ab Et Al (PMNOC - Section 8 - Zolpidem*) | Montréal | 8 d |
| Nov 15, 2021 | T-353-20 | Celgene Inc. Et Al V. Natco Pharma (canada)inc. (Patent - Pomalidomide*) | Toronto | 15 d |
| Nov 15, 2021 | T-327-19 | Paypal, Inc. V. One 97 Communications Ltd. Et Al (Trade Mark) | Toronto | 12 d |
| Nov 16, 2021 | T-347-20 | Eisai Limited Et Al V. Taro Pharmaceuticals Inc. (Patent - Perampanel*) | Toronto | 11 d |
| Dec 2, 2021 | T-418-20 | Merck Sharp & Dohme Corp Et Al. V. Sandoz Canada Inc (Patent - Sitagliptin*) | Toronto | 12 d |
| Dec 2, 2021 | T-419-20 | Merck Sharp & Dohme Corp Et Al. V. Pharmascience Inc. (Patent - Sitagliptin*) | Toronto | 12 d |
| Dec 6, 2021 | T-270-20 | Bayer Inc. Et Al V. Pharmascience Inc. (Patent) | Ottawa | 10 d |
| Jan 17, 2022 | T-1660-11 | Bernard Charles Sherman Et Al V. Pfizer Canada Inc., Et Al (Patent - Quinapril*) | Toronto | 10 d |
| Jan 17, 2022 | T-827-20 | Viiv Healthcare Company, Shionogi & Co., Ltd. Et Al. V. Sandoz Canada Inc. (Patent - Dolutegravir*) | Toronto | 10 d |
| Jan 24, 2022 | T-549-20 | Janssen Inc. Et Al. V. Sandoz Canada Inc. (Patent - Macitentan*) | Toronto | 7 d |
| Feb 7, 2022 | T-555-20 | Janssen Inc. Et Al. V. Apotex Inc. (Patent - Apixaban*) | Toronto | 5 d |
| Feb 7, 2022 | T-524-20 | Allergan Inc. V. Pharmascience Inc. Et Al. (Patent - Silodosin*) | Toronto | 10 d |
| Feb 14, 2022 | T-1066-17 | T-rex Property Ab V. Pattison Outdoor Advertising Limited Partnership Et Al (Patent) | Toronto | 15 d |
| Feb 14, 2022 | T-1935-13 | Bernard Charles Sherman Et Al V. Pharmascience Inc (Patent - Quinapril*) | Toronto | 10 d |
| Feb 28, 2022 | T-666-20 | Merck Sharp & Dohme Corp Et Al V. Apotex Inc. (Patent - Sitagliptin*) | Toronto | 10 d |
| Feb 28, 2022 | T-560-20 | Merck Sharp& Dohme Corp Et Al V. Apotex Inc (Patent - Sitagliptin*) | Toronto | 10 d |
| Feb 28, 2022 | T-561-20 | Merck Sharp & Dohme Corp. Et Al V. Apotex Inc. (Patent - Sitagliptin*) | Toronto | 10 d |
| Feb 28, 2022 | T-563-20 | Merck Sharp & Dohme Corp. Et Al V Apotex Inc. (Patent - Sitagliptin*) | Toronto | 10 d |
| Feb 28, 2022 | T-665-20 | Merck Sharp & Dohme Corp Et Al V. Apotex Inc. (Patent - Sitagliptin*) | Toronto | 10 d |
| Mar 14, 2022 | T-1769-19 | Tekna Plasma Systems Inc. V. Ap&c Advanced Powders & Coatings Inc. (Patent) | Montréal | 24 d |
| Mar 14, 2022 | T-126-19 | Tekna Plasma Systems Inc. V. Ap&c Advanced Powders & Coatings Inc. (Patent) | Montréal | 24 d |
| Mar 14, 2022 | T-886-20 | Galderma Canada Inc. Et Al. V. Sandoz Canada Inc. (Patent - Doxycycline*) | Toronto | 10 d |
| Mar 21, 2022 | T-1861-17 | Denis Cimaf Inc. C. Fecon Inc. (Trade Mark) | Ottawa | 10 d |
| Mar 28, 2022 | T-667-20 | Merck Sharp & Dohme Corp. Et Al V. Jamp Pharma Corporation (Patent - Sitagliptin*) | Toronto | 10 d |
| Mar 28, 2022 | T-798-20 | Opiant Pharmaceuticals Inc. Et Al V. Teva Canada Ltd. (Patent - Naloxone*) | Toronto | 10 d |
| Mar 28, 2022 | T-1187-20 | Merck Sharp & Dohme Corp. Et Al V. Jamp Pharma Corporation (Patent - Sitagliptin*) | Toronto | 10 d |
| Apr 4, 2022 | T-769-20 | Janssen Inc. Et Al. V. Jamp Pharma Corporation (Patent - Macitentan*) | Toronto | 10 d |
| Apr 25, 2022 | T-671-20 | Sunovion Pharmaceuticals Canada Inc. Et Al V. Taro Pharmaceuticals Inc. (Patent - Lurasidone*) | Toronto | 10 d |
| May 9, 2022 | T-989-20 | Janssen Inc. Et Al V. Jamp Pharma Corporation (Patent - Abiraterone*) | Toronto | 10 d |
| May 30, 2022 | T-2009-19 | Samsung Bioepis Co.,ltd. V. Fresenius Kabi Deutschlandf Gmbh (Patent - Adalimumab*) | Toronto | 10 d |
| May 30, 2022 | T-1581-20 | Celgene Inc. Et Al V. Natco Pharma (canada) Inc. (Patent - Pomalidomide*) | Toronto | 7 d |
| Jun 6, 2022 | T-13-20 | Andritz Ltd Et Al. V. Cortex North America Corporation (Patent) | Montréal | 12 d |
| Jun 6, 2022 | T-891-20 | Sunovion Pharmaceuticals Canada Inc. Et Al V. Jamp Pharma Corporation (Patent - Lurasidone*) | Toronto | 10 d |
| Jun 13, 2022 | T-1285-20 | Janssen Inc. Et Al V. Natco Pharma (canada) Inc. (Patent - Abiraterone*) | Toronto | 10 d |
| Jun 13, 2022 | T-952-20 | Google Llc V. Sonos, Inc. (Patent) | Toronto | 10 d |
| Jul 4, 2022 | T-602-20 | Merck Sharp & Dohme Corp. Et Al. V. Apotex Inc. (Patent - Sitagliptin*) | Toronto | 10 d |
| Jul 4, 2022 | T-668-20 | Merck Sharp & Dohme Corp. Et Al V. Jamp Pharma Corporation (Patent - Sitagliptin*) | Toronto | 10 d |
| Jul 4, 2022 | T-670-20 | Merck Sharp & Dohme Corp, Et Al V. Sandoz Canada Inc. (Patent - Sitagliptin*) | Toronto | 10 d |
| Jul 4, 2022 | T-673-20 | Merck Sharp & Dohme Corp. Et Al V. Pharmascience Inc. (Patent - Sitagliptin*) | Toronto | 10 d |
| Jul 4, 2022 | T-601-20 | Merck Sharp & Dohme Corp Et Al. V. Apotex Inc. (Patent - Sitagliptin*) | Toronto | 10 d |
| Jul 4, 2022 | T-1441-20 | Janssen Inc. Et Al V. Pharmascience Inc. (Patent - Paliperidone*) | Toronto | 10 d |
| Jul 5, 2022 | T-1207-20 | Pfizer Canada Ulc Et Al. V. Jamp Pharma Corporation (Patent - Tofacitinib*) | Toronto | 9 d |
| Aug 2, 2022 | T-1268-20 | Janssen Inc. Et Al. V. Sandoz Canada Inc (Patent - Canagliflozin*) | Toronto | 10 d |
| Aug 15, 2022 | T-1467-20 | Celgene Inc. Et Al V. Taro Pharmaceuticals Inc. (Patent - Lenalidomide*) | Toronto | 15 d |
| Sep 12, 2022 | T-1528-20 | Bausch Health Ireland Ltd Et Al V. Sandoz Canada Inc. (Patent - Efinaconazole*) | Montréal | 10 d |
| Sep 26, 2022 | T-124-21 | Janssen Inc. Et Al V. Apotex Inc. (Patent - Paliperidone*) | Toronto | 10 d |
| Oct 17, 2022 | T-6-21 | Merck Sharp & Dohme Corp. Et Al V. Sandoz Canada Inc. (Patent - Sitagliptin*) | Toronto | 7 d |
Return to top.
Scheduled Judicial Review Hearings
| Date | File No. | Name | Type | Location | Length |
| Mar 15, 2021 | T-1485-17 | Beverly Hills Jewellers Mfg Ltd. V. Corona Jewellery Company Ltd. | S. 18.1 Application for Judicial Review | Toronto | 2 d |
| Mar 22, 2021 | T-546-20 | International Name Plate Supplies Limited V. Marks & Clerk Canada | Trade Mark - Appeal of a decision of the Registrar | Toronto | 1 d |
| Apr 8, 2021 | T-1476-20 | Merck Canada Inc. The Minister Of Health - Pembrolizumab* | S. 18.1 Application for Judicial Review | Toronto | 1 d |
| Jun 2, 2021 | T-1471-19 | Merck Canada Inc. V. The Minister Of Health - Suvorexant* | S. 18.1 Application for Judicial Review | Toronto | 1 d |
Return to top.
Scheduled IP Appeals
| Date | File No. | Name | Type | Location | Length |
| Mar 9, 2021 | A-91-20 | Spectrum Brands Inc. V. Schneider Electric Industries Sas | Appeal (S.27 - Final) - Trade-marks Act | Ottawa | 3 h |
| Mar 17, 2021 | A-269-20 | Google Canada Corporation, Et Al. V. Paid Search Engines Tools, Llc | Appeal (S.27 - Interloc.) - Patent Act [from T-40-18 - Patent Infringement] | Ottawa | 2 h |
| Mar 24, 2021 | A-440-19 | Teksavvy Solutions Inc. V. Bell Media Inc., Et Al. | Appeal (S.27 - Interloc.) - Copyright Act [from T-1169-19 - Copyright Infringement [Actions]] | Ottawa | 1.3 d |
* Medicinal ingredients are based on automated analysis and should not be relied upon.
Return to top.